Children (Jul 2022)

Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

  • Silvia Bloise,
  • Alessia Marcellino,
  • Vanessa Martucci,
  • Mariateresa Sanseviero,
  • Alessia Testa,
  • Emanuela Del Giudice,
  • Mattia Spatuzzo,
  • Daniel Sermoneta,
  • Flavia Ventriglia,
  • Riccardo Lubrano

DOI
https://doi.org/10.3390/children9070993
Journal volume & issue
Vol. 9, no. 7
p. 993

Abstract

Read online

At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine.

Keywords